Trademark applications and grants for Pieris Pharmaceuticals G M B H. Pieris Pharmaceuticals G M B H has 3 trademark applications. The latest application filed is for "MABCALIN"
Patent Application | Date |
---|---|
ENGINEERED T CELLS AND USES THEREFOR 20220296690 - 17/664731 Hinner; Marlon | 2022-09-22 |
INHALED ADMINISTRATION OF LIPOCALIN MUTEINS 20220168387 - 17/599765 MATSCHINER; Gabriele ;   et al. | 2022-06-02 |
Novel Fusion Proteins Specific for CD137 and GPC3 20220153864 - 17/433155 BEL AIBA; Rachida Siham ;   et al. | 2022-05-19 |
NOVEL PROTEINS SPECIFIC FOR CD137 20220144901 - 17/579392 HINNER; Marlon ;   et al. | 2022-05-12 |
LIPOCALIN MUTEINS WITH BINDING AFFINITY FOR LAG-3 20220098253 - 17/499640 Rothe; Christine ;   et al. | 2022-03-31 |
Mark Image Registration | Serial | Trademark Application Date |
---|---|
![]() "MABCALIN" 79361821 |
MABCALIN 2022-12-19 |
![]() "PIERIS" 3891767 77638905 |
PIERIS 2008-12-23 |
![]() "ANTICALIN" 3081539 78143412 |
ANTICALIN 2002-07-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.